Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124


An analysis of p53, BAX and vascular endothelial growth factor expression in node-positive rectal cancer. Relationships with tumour recurrence and event-free survival of patients treated with adjuvant chemoradiation.

Cascinu S, Graziano F, Catalano V, Staccioli MP, Rossi MC, Baldelli AM, Barni S, Brenna A, Secondino S, Muretto P, Catalano G.

Br J Cancer. 2002 Mar 4;86(5):744-9.


Vascular endothelial growth factor expression, S-phase fraction and thymidylate synthase quantitation in node-positive colon cancer: relationships with tumor recurrence and resistance to adjuvant chemotherapy.

Cascinu S, Graziano F, Valentini M, Catalano V, Giordani P, Staccioli MP, Rossi C, Baldelli AM, Grianti C, Muretto P, Catalano G.

Ann Oncol. 2001 Feb;12(2):239-44.


Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.

Giatromanolaki A, Sivridis E, Stathopoulos GP, Fountzilas G, Kalofonos HP, Tsamandas A, Vrettou E, Scopa C, Polychronidis A, Simopoulos K, Koukourakis MI.

Anticancer Res. 2001 Jan-Feb;21(1A):253-9.


Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.

Fontanini G, Vignati S, Lucchi M, Mussi A, Calcinai A, Boldrini L, Chiné S, Silvestri V, Angeletti CA, Basolo F, Bevilacqua G.

Br J Cancer. 1997;75(9):1295-301.


The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy.

Manders P, Beex LV, Tjan-Heijnen VC, Geurts-Moespot J, Van Tienoven TH, Foekens JA, Sweep CG.

Br J Cancer. 2002 Sep 23;87(7):772-8.


Expression of angiogenic factors and apoptotic factors in leiomyosarcoma and leiomyoma.

Hong T, Shimada Y, Uchida S, Itami A, Li Z, Ding Y, Kaganoi J, Komoto I, Sakurai T, Imamura M.

Int J Mol Med. 2001 Aug;8(2):141-8.


Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.

Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC.

Clin Cancer Res. 1998 Dec;4(12):3017-24.


BAX and p16INK4A are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer.

Gessner C, Liebers U, Kuhn H, Stiehl P, Witt C, Schauer J, Wolff G.

Eur Respir J. 2002 Jan;19(1):134-40.


p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer.

Fondevila C, Metges JP, Fuster J, Grau JJ, Palacín A, Castells A, Volant A, Pera M.

Br J Cancer. 2004 Jan 12;90(1):206-15.


Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.

Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.

BMC Cancer. 2007 Apr 12;7:63.


Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.

Gasparini G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Boracchi P, Gatti C, Suzuki H, Tominaga T.

J Natl Cancer Inst. 1997 Jan 15;89(2):139-47.


Expression of p53 and vascular endothelial growth factor associated with tumor angiogenesis and prognosis in gastric cancer.

Maeda K, Kang SM, Onoda N, Ogawa M, Sawada T, Nakata B, Kato Y, Chung YS, Sowa M.

Oncology. 1998 Nov-Dec;55(6):594-9.


The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.

Linderholm BK, Lindahl T, Holmberg L, Klaar S, Lennerstrand J, Henriksson R, Bergh J.

Cancer Res. 2001 Mar 1;61(5):2256-60.


Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival.

Rosati G, Chiacchio R, Reggiardo G, De Sanctis D, Manzione L.

Tumour Biol. 2004 Sep-Dec;25(5-6):258-63.


The prognostic importance of p53, bcl-2, and bax in early stage epithelial ovarian carcinoma treated with adjuvant chemotherapy.

Skirnisdóttir I, Seidal T, Gerdin E, Sorbe B.

Int J Gynecol Cancer. 2002 May-Jun;12(3):265-76.


p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer.

Schwandner O, Schiedeck TH, Bruch HP, Duchrow M, Windhoevel U, Broll R.

Eur J Cancer. 2000 Feb;36(3):348-56.

Items per page

Supplemental Content

Write to the Help Desk